Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01692613
Other study ID # A139/12
Secondary ID
Status Completed
Phase N/A
First received September 20, 2012
Last updated June 2, 2015
Start date September 2012
Est. completion date September 2014

Study information

Verified date June 2015
Source University of Schleswig-Holstein
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Observational

Clinical Trial Summary

Background:

The immediate endoscopic identification and diagnosis of intraepithelial structures and immediate and delayed reactions to allergens in the mucosal surface of the gut are unmet goals in the diagnosis and management of subjects with food intolerances, who are negative to all available tests. Endomicroscopy may be helpful to further visualize and characterize unmasked small bowel reactions to foods, which has not been described before.

Confocal laser endomicroscopy provides confocal microscopic imaging simultaneously to the macroscopic view ,which enables the examiner to see immediate reactions after exposure and it further allows capturing of fluid excreted by the gut for further analysis to understand the pathology behind this reaction further.

N=50 patients with unexplained bloating and diarrhoea with suspicion of food intolerance and negative testing with routine methods. Patients with Lactose intolerance n=10 patients to compare results. Patients with Fructose intolerance n=10 patients to compare results. Volunteers with Barrett's esophagus who need evaluation for possible dysplasia in the Barrett's mucosa with confocal endomicrosopy but no symptoms of bloating and abdominal pain (n=10) to serve as healthy controls for allergy testing.

Methods:

The primary objective is to investigate whether endomicroscopy will allow the detection of an allergic reaction of the gut after exposure of the 5 major allergens in the following way:

After standard gastroscopy with the endomicroscope including evaluation of the surface of the upper gastrointestinal tract, i.v. injection of Fluorescein, then initial visualisation of the duodenal surface including count of initial lymphocytes/mononuclear cells in the lamina propria: Allergen 1 (milk), allergen 2 (wheat), allergen 3 (soya),allergen 4 (apple), allergen 5 (yeast).

The primary endpoint is the visible marked increase of lymphocytes and mononuclear cells in the lamina propria of the duodenum, representing an acute reaction to one of the allergens sprayed to its surface through the endoscope channel.


Description:

The primary endpoint is the visible marked increase of lymphocytes and mononuclear cells in the lamina propria of the duodenum, representing an acute reaction to one of the allergens sprayed to its surface through the endoscope channel.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- age > 18 years

- ongoing abdominal symptoms such as bloating and abdominal pain

- negative routine testing for food intolerance (or known lactose/fructose intolerance)

- written informed consent

Exclusion Criteria:

- no consent

- known reason for the abdominal pain and bloating other than lactose/fructose intolerance

- M. Whipple

- known infectious gastrointestinal disease

- stricture in the upper gastrointestinal tract

- age >18years

- impaired renal function (Creatinine >1.2 mg/dL)

- pregnancy or breast feeding

- inability to obtain informed consent

- active GI Bleeding

- known allergy to Methylene blue or Fluorescein

- participation in other clinical trials within the last 4 weeks

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Locations

Country Name City State
Germany University Hospital Schleswig Holstein, Campus Kiel, Unit Experimental Endoscopy Kiel

Sponsors (3)

Lead Sponsor Collaborator
University of Schleswig-Holstein Great Ormond Street Hospital for Children NHS Foundation Trust, Johannes Gutenberg University Mainz

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of mucosal reaction immediate No
See also
  Status Clinical Trial Phase
Withdrawn NCT02313207 - Confocal Laser Endomicroscopy in IBS Patients N/A
Recruiting NCT06338189 - The 5Ad Diet for Functional Bowel Disorders N/A
Completed NCT03137862 - "Gluten Friendly" Treatment in Celiac Disease N/A
Completed NCT05482997 - Athlete Whey Protein Sensitivity: Prevalence and Performance N/A
Completed NCT03826576 - Healthy Meals: A Restaurant-based Study to Promote Healthy and Allergy Adapted Diet N/A
Recruiting NCT06379373 - Peripheral Mechanisms of Humoral Immune Effector-mediated Tourette's Syndrome and the Role of Tuina Intervention N/A
Recruiting NCT06151782 - Immunosafe-CeD: Are Partially Hydrolysed Gluten Hamrful to Celiac Disease Patients? N/A
Recruiting NCT04653324 - A Registry for the Food Allergy Community
Completed NCT03298568 - Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity N/A
Completed NCT01603719 - Efficacy and Safety of an Infant Formula With Milkfat and Prebiotics N/A
Recruiting NCT05802017 - Relation Between Adverse Reactions to Food, Physical Performance and Health in a Mediterranean Population N/A
Completed NCT03143517 - Fecal Calprotectin Collection Protocol
Recruiting NCT06392061 - Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease N/A
Not yet recruiting NCT03885479 - Impact of Different Dietary IgGs on the Pathogenesis of IBD